Sub Banner Image

ISRG's International Push for Ion: Strategic Bet or Overstretch?

Equities

Zacks Investment Research

·

August 19, 2025

·

Barchart

Intuitive Surgical ISRG is doubling down on its Ion platform’s global prospects, marking its first commercial system sales in Australia and Korea during the second quarter of  2025. The expansion comes as Ion continues its remarkable momentum, with procedures surging 52% year over year to nearly 35,000 in the quarter....

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.